These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29786960)

  • 1. Atomic-Resolution Structure of a Class C β-Lactamase and Its Complex with Avibactam.
    Pozzi C; Di Pisa F; De Luca F; Benvenuti M; Docquier JD; Mangani S
    ChemMedChem; 2018 Jul; 13(14):1437-1446. PubMed ID: 29786960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases.
    Lahiri SD; Mangani S; Durand-Reville T; Benvenuti M; De Luca F; Sanyal G; Docquier JD
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2496-505. PubMed ID: 23439634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.
    Pemberton OA; Noor RE; Kumar M V V; Sanishvili R; Kemp MT; Kearns FL; Woodcock HL; Gelis I; Chen Y
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5818-5825. PubMed ID: 32123084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance.
    Lahiri SD; Johnstone MR; Ross PL; McLaughlin RE; Olivier NB; Alm RA
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5704-13. PubMed ID: 25022578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48.
    Lahiri SD; Mangani S; Jahić H; Benvenuti M; Durand-Reville TF; De Luca F; Ehmann DE; Rossolini GM; Alm RA; Docquier JD
    ACS Chem Biol; 2015 Feb; 10(2):591-600. PubMed ID: 25406838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme.
    Lahiri SD; Giacobbe RA; Johnstone MR; Alm RA
    J Antimicrob Chemother; 2014 Nov; 69(11):2942-6. PubMed ID: 24986496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant
    Alexander JAN; Radaeva M; King DT; Chambers HF; Cherkasov A; Chatterjee SS; Strynadka NCJ
    J Biol Chem; 2020 Aug; 295(32):10870-10884. PubMed ID: 32518158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam.
    Wang DY; Abboud MI; Markoulides MS; Brem J; Schofield CJ
    Future Med Chem; 2016 Jun; 8(10):1063-84. PubMed ID: 27327972
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Lohans CT; Wang DY; Jorgensen C; Cahill ST; Clifton IJ; McDonough MA; Oswin HP; Spencer J; Domene C; Claridge TDW; Brem J; Schofield CJ
    Org Biomol Chem; 2017 Jul; 15(28):6024-6032. PubMed ID: 28678295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections.
    Nicolau DP
    Expert Opin Investig Drugs; 2015; 24(9):1261-73. PubMed ID: 26145447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the Mechanism of Inactivation of the FOX-4 Cephamycinase by Avibactam.
    Nukaga M; Papp-Wallace KM; Hoshino T; Lefurgy ST; Bethel CR; Barnes MD; Zeiser ET; Johnson JK; Bonomo RA
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
    Pillar CM; Stoneburner A; Shinabarger DL; Krause KM; Nichols WW
    Lett Appl Microbiol; 2016 Aug; 63(2):96-102. PubMed ID: 27221329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study.
    Krishnan NP; Nguyen NQ; Papp-Wallace KM; Bonomo RA; van den Akker F
    PLoS One; 2015; 10(9):e0136813. PubMed ID: 26340563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections.
    Shirley M
    Drugs; 2018 Apr; 78(6):675-692. PubMed ID: 29671219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations.
    Lahiri SD; Bradford PA; Nichols WW; Alm RA
    J Antimicrob Chemother; 2016 Oct; 71(10):2848-55. PubMed ID: 27402011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.